Effect of I-PRF Application on ALP and MMP-9 Levels in Teeth With Apical Periodontitis
NCT ID: NCT07320898
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2025-01-01
2025-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
i-PRF & Root Surface Biomodification
NCT07207668
Examination of the Effect of Nd:YAG Laser on Oxidative Stress and Matrix Metalloproteinase-9 in Teeth With Apical Periodontitis
NCT07243353
Evaluation of Repeated Injectable PRF Following SRP in Patients With Periodontitis
NCT07029035
Relationship Apical Periodontitis and the Main Bacterial Species in the Oral Microbiota
NCT05857436
Injectable Platelet Rich Fibrin in Periodontal Treatment
NCT06814418
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sterile paper points were used to collect periapical exudate samples from teeth after the shaping and irrigation protocols were completed. The root canals were dried to the working length using a #40 paper point. The #20 paper points, adjusted to a length 2 mm longer than the working length, were moved 2 mm from the apical stop and held for 1 minute. The process was repeated three times. A 4-mm cut was made at the ends of the periapical exudate-impregnated paper points with sterile surgical scissors, and the resulting segments were transferred to the Eppendorf tubes. After collecting the periapical sample, calcium hydroxide paste was placed in the canal. The tooth was temporarily sealed with composite resin to prevent contamination between sessions.
The procedures described above were performed identically in both groups. In the i-PRF group, five cc of blood was collected from the patients' antecubital vein into a glass-coated plastic tube without anticoagulant. I-PRF was centrifuged at 700 rpm for 3 minutes. After centrifugation, the i-PRF obtained at the top of the tube was collected using a syringe. The canal length measured during treatment was used to apply i-PRF at the point closest to the tooth apex. To ensure standardization across all patients, 0.5 cc of i-PRF was injected submucosally at the designated site. In the second session, following isolation and disinfection as described in the first session, GCF samples were collected, and after the final irrigation procedure, PAE samples were collected. The root canals were obturated by the lateral condensation method using gutta-percha cones and root canal sealer. Permanent restorations were made with composite resin. The samples were analyzed with ELISA. Data analysis was performed using SPSS 27.0, and a 95% confidence level was achieved. Frequency and percentage (n (%)) are given for categorical (qualitative) variables, while mean, standard deviation, minimum, maximum, and median values are given for numerical (quantitative) variables. The dependent-samples t-test and the Wilcoxon test were used for repeated measurements in the study. The independent-samples t-test and Mann-Whitney U test were used to compare groups. The Spearman correlation test was used for relationships between measurements.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
30 participants. Procedure: Root canal treatment without i-PRF application. Collection of GCF and PAE samples.
No interventions assigned to this group
I-PRF Group
30 participants. Procedure: i-PRF application and root canal treatment. Collection of GCF and PAE samples.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients aged 18-64
* Upper or lower incisors and premolars with primary apical periodontitis
* Patients with ASA I
* Patients who have provided written informed consent to participate in the study.
Exclusion Criteria
* Patients who have used antibiotics and anti-inflammatory medications within the last month,
* Patients with a periodontal pocket greater than 3 mm in the affected tooth,
* Teeth with internal or external root resorption, or teeth with swelling and pain on palpation,
* Pregnant women or those suspected of pregnancy,
* Patients with generalized periodontitis,
* Patients with immunosuppressive systemic diseases such as diabetes and hepatitis will not be included in the study.
18 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kırıkkale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ali Turkyilmaz
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gamze E NALBANT, Research Assistant
Role: PRINCIPAL_INVESTIGATOR
Kirikkale University Faculty of Dentistry
Ali Türkyılmaz, Associate Professor
Role: STUDY_CHAIR
Kirikkale University Faculty of Dentistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kırıkkale University, Faculty of Dentistry
Kırıkkale, Kırıkkale, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024/17 - 2024.12.22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.